• BIVDA members area

Members' Press Releases

From the monthly archives: July, 2015

We are pleased to present below all posts archived in 'July, 2015'. If you still can't find what you are looking for, try using the search box.

New bench-top clinical chemistry analyzer launched by EKF Diagnostics at AACC 2015

EKF Diagnostics

Cardiff, UK – 23rd July 2015 – EKF Diagnostics, the global in vitro diagnostics company, announces the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga, 26-30 July. This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. 

Read the rest of entry »

FABPulous wins €1.6m EU grant for clinical trials of 5 minute heart attack test

FABPulous

July 20th 2015, Maastricht (Netherlands) - The European Union awarded FABPulous BV a 1.6 million Phase 2 grant to fund two clinical trials in the UK and Belgium/Netherlands and automate the manufacture of its 5 minute, patented H-FABP True Rapid Test, which helps emergency medical workers quickly distinguish whether a patient with chest pain is at risk of a heart attack.

Read the rest of entry »

Cytox and Affymetrix form strategic partnership to develop and commercialize blood-based genetic assay

Cytox

20 July 2015: Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI).

Read the rest of entry »

EKF Diagnostics’ Growth Drives New Role Creation

EKF Diagnostics

Expanding business welcomes new faces to further strengthen IVD expertise and new product development.

Read the rest of entry »

IBDoc® - Supporting New Standards of Care for IBD The first CE marked Calprotectin Home Test

Alpha Laboratories

Managing chronic conditions such as diabetes and hypertension through patient self-testing has become common place. It is now also possible for sufferers of inflammatory bowel disease (IBD) to manage their condition from home. The new BÜHLMANN IBDoc® system, now available from Alpha Laboratories, utilises sophisticated technology that enables IBD patients to perform quantitative faecal calprotectin testing themselves, in just three easy steps, reading the results using their smartphones.

Read the rest of entry »

Proteome Sciences to deliver ground-breaking programmes with CK1d, SysQuant® & TMTcalibrator™ at AAIC 2015

Proteome Sciences

Cobham, UK – July 8th, 2015. Proteome Sciences plc (‘Proteome Sciences’) will present news and results across different aspects of its Alzheimer’s research programmes at the upcoming Alzheimer’s Association International Conference® 2015 (AAIC®) taking place in Washington, D.C., USA from 18-23 July, 2015.

Read the rest of entry »

Archive